Sports-Related Gastrointestinal Disorders: From the Microbiota to the Possible Role of Nutraceuticals, a Narrative Analysis.
Alexander BertuccioliGiordano Bruno ZonziniMassimiliano CazzanigaMarco CardinaliFrancesco Di PierroAurora GregorettiNicola ZerbinatiLuigina GuastiMaria Rosaria MateraIlaria CavecchiaChiara Maria PalazziPublished in: Microorganisms (2024)
Intense physical exercise can be related to a significant incidence of gastrointestinal symptoms, with a prevalence documented in the literature above 80%, especially for more intense forms such as running. This is in an initial phase due to the distancing of the flow of blood from the digestive system to the skeletal muscle and thermoregulatory systems, and secondarily to sympathetic nervous activation and hormonal response with alteration of intestinal motility, transit, and nutrient absorption capacity. The sum of these effects results in a localized inflammatory process with disruption of the intestinal microbiota and, in the long term, systemic inflammation. The most frequent early symptoms include abdominal cramps, flatulence, the urge to defecate, rectal bleeding, diarrhea, nausea, vomiting, regurgitation, chest pain, heartburn, and belching. Promoting the stability of the microbiota can contribute to the maintenance of correct intestinal permeability and functionality, with better control of these symptoms. The literature documents various acute and chronic alterations of the microbiota following the practice of different types of activities. Several nutraceuticals can have functional effects on the control of inflammatory dynamics and the stability of the microbiota, exerting both nutraceutical and prebiotic effects. In particular, curcumin, green tea catechins, boswellia, berberine, and cranberry PACs can show functional characteristics in the management of these situations. This narrative review will describe its application potential.
Keyphrases
- skeletal muscle
- systematic review
- risk factors
- oxidative stress
- healthcare
- drug induced
- primary care
- sleep quality
- atrial fibrillation
- insulin resistance
- metabolic syndrome
- heart failure
- aortic valve
- escherichia coli
- depressive symptoms
- quality improvement
- high intensity
- climate change
- polycystic ovary syndrome
- adipose tissue
- cystic fibrosis
- biofilm formation
- pseudomonas aeruginosa
- risk assessment
- clostridium difficile
- extracorporeal membrane oxygenation